Credit Suisse’s ImageneBio Inc IMA Stock Holding History

Credit Suisse’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	–	–	4145
2022 Q2	$0	Buy	+1	New	+$55	﹤0.01%	4106
2021 Q4	–	Sell	-16,648	Closed	-$2.52M	–	4586
2021 Q3	$2.52M	Sell	16,648 -8,570	-34%	-$1.25M	﹤0.01%	2640
2021 Q2	$4.25M	Buy	25,218 +23,183	+1,139%	+$5.11M	﹤0.01%	2214
2021 Q1	$690K	Buy	+2,035	New	+$697K	﹤0.01%	3557

Other funds holding IMA

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse's IMA Position: Q3 2022 in Review

Credit Suisse sold out of ImageneBio Inc (IMA) in Q3 2022, closing a stake of 1 share.

Credit Suisse first reported a position in IMA in Q1 2021 and held it in 4 quarters. The position peaked at $4.25M in Q2 2021. 42 funds tracked by Wall St. Rank hold IMA as of Q3 2022.

Credit Suisse reported no remaining ImageneBio Inc position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 1 ImageneBio Inc share in Q3 2022.
Credit Suisse first reported a position in ImageneBio Inc in Q1 2021 and held it in 4 quarters.
Credit Suisse's ImageneBio Inc position peaked at $4.25M in Q2 2021.
42 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.